Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}} Now: 1770476047211 Cache Key: cqdTagPageBySlug:aortic-stenosis fetchCache[cqdTagPageBySlug:aortic-stenosis].expirationTime: falsey fetchCache[cqdTagPageBySlug:aortic-stenosis]. seconds remaining: falsey All fetchCache expiration times: -- Key: cqdNotFoundPage, seconds remaining: 5273 -- Key: cqdTagPageBySlug:preoperative-assessment, seconds remaining: -13434 -- Key: cqdPostsByTag:cqd-migrated-tag-23398,1,10, seconds remaining: -13366 -- Key: cqdTagPageBySlug:aao-hns-guidelines, seconds remaining: -13061 -- Key: cqdPostsByTag:cqd-migrated-tag-25768,1,10, seconds remaining: -12988 -- Key: cqdTagPageBySlug:fitness, seconds remaining: -10416 -- Key: cqdPostsByTag:cqd-migrated-tag-19049,1,10, seconds remaining: -10345 -- Key: cqdTagPageBySlug:7-tesla-7t, seconds remaining: -10057 -- Key: cqdPostsByTag:cqd-migrated-tag-4081,1,10, seconds remaining: -9887 -- Key: cqdTagPageBySlug:venu-menon, seconds remaining: -9411 -- Key: cqdPostsByTag:cqd-migrated-tag-2481,1,10, seconds remaining: -9341 -- Key: cqdTagPageBySlug:vascular-core-laboratory, seconds remaining: -8674 -- Key: cqdPostsByTag:cqd-migrated-tag-19208,1,10, seconds remaining: -8604 -- Key: cqdTagPageBySlug:type-2-diabetes-t2d, seconds remaining: 5273 -- Key: cqdPostsByTag:cqd-migrated-tag-20755,1,10, seconds remaining: 5350 -- Key: cqdTagPageBySlug:histopathology, seconds remaining: 5455 -- Key: cqdPostsByTag:cqd-migrated-tag-422,1,10, seconds remaining: 5525 conditions: -- false, -- NA, -- NA, -- NA -- false Cache miss for key cqdTagPageBySlug:aortic-stenosis - retrieving from Sanity CCCache.dataFetchCount: 5508 Cache cleanup seconds remaining: 6566
Advertisement
Advertisement
Age and other factors figure into the choice among SAVR, TAVR, Ross, Ozaki and more
Optimally timed valve replacement depends on an expert approach to nuanced presentations
Aortic valve replacement is best option for lowering mortality in this high-risk population
Large longitudinal study supports earlier intervention over clinical surveillance
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Support for a TAVR-first approach in patients with concurrent valve and coronary disease
Five-year data demonstrate convergence of outcomes from years 1 to 5
Randomized WATCH-TAVR trial confirms safety of the combined procedures
Potential benefits include clinical guidance, TAVR outcome prediction, device testing
Sophisticated in vivo modeling can enhance device development and therapy testing
Observational findings over 5+ years of follow-up argue for caution in this population
Rendered: Sat Feb 07 2026 14:54:07 GMT+0000 (Coordinated Universal Time)
9500 Euclid Avenue, Cleveland, Ohio 44195 |
800.223.2273 | ©
2026 Cleveland Clinic. All Rights Reserved.